Abeona Therapeutics (ABEO) Revenue & Revenue Breakdown
Abeona Therapeutics Revenue Highlights
Latest Revenue (Y)
$5.82M
Latest Revenue (Q)
$11.38M
Main Segment (Y)
License
Main Geography (Y)
License and Other Revenues
Abeona Therapeutics Revenue by Period
Abeona Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $5.82M | 100.00% |
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $3.50M | 147.52% |
| 2022-12-31 | $1.41M | -52.87% |
| 2021-12-31 | $3.00M | -70.00% |
| 2020-12-31 | $10.00M | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $3.00M | 258.18% |
| 2017-12-31 | $837.00K | -5.85% |
| 2016-12-31 | $889.00K | -14.52% |
| 2015-12-31 | $1.04M | 12.43% |
| 2014-12-31 | $925.00K | -54.70% |
| 2013-12-31 | $2.04M | -53.63% |
| 2012-12-31 | $4.40M | 138.31% |
| 2011-12-31 | $1.85M | 284.20% |
| 2010-12-31 | $481.00K | 36.65% |
| 2009-12-31 | $352.00K | 20.96% |
| 2008-12-31 | $291.00K | 410.53% |
| 2007-12-31 | $57.00K | 100.00% |
| 2006-12-31 | - | 100.00% |
| 2005-12-31 | - | -100.00% |
| 2004-12-31 | $549.00K | -57.61% |
| 2003-12-31 | $1.29M | 12.90% |
| 2002-12-31 | $1.15M | 372.02% |
| 2001-12-31 | $243.00K | 127.10% |
| 2000-12-31 | $107.00K | 613.33% |
| 1999-12-31 | $15.00K | -85.00% |
| 1998-12-31 | $100.00K | -77.01% |
| 1997-12-31 | $435.00K | 160.48% |
| 1996-12-31 | $167.00K | -94.33% |
| 1995-12-31 | $2.94M | - |
Abeona Therapeutics generated $5.82M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 58.20% compared to the same period a year ago.
Abeona Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $11.38M | 30.50% |
| 2026-03-31 | $8.72M | 60.89% |
| 2025-12-31 | $5.42M | 100.00% |
| 2025-09-30 | - | -100.00% |
| 2025-06-30 | $400.00K | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $3.50M | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $68.00K | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $1.00M | 189.02% |
| 2022-03-31 | $346.00K | -88.47% |
| 2021-12-31 | $3.00M | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $3.00M | -57.14% |
| 2020-09-30 | $7.00M | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | -100.00% |
| 2018-12-31 | $-2.13M | -224.52% |
| 2018-09-30 | $1.71M | 519.20% |
| 2018-06-30 | $276.00K | -89.38% |
| 2018-03-31 | $2.60M | 1108.37% |
| 2017-12-31 | $215.00K | -1.83% |
| 2017-09-30 | $219.00K | 0.92% |
| 2017-06-30 | $217.00K | 16.67% |
| 2017-03-31 | $186.00K | -27.34% |
| 2016-12-31 | $256.00K | 39.13% |
| 2016-09-30 | $184.00K | -14.02% |
| 2016-06-30 | $214.00K | -8.94% |
| 2016-03-31 | $235.00K | 9.30% |
| 2015-12-31 | $215.00K | -24.56% |
| 2015-09-30 | $285.00K | 1.06% |
| 2015-06-30 | $282.00K | 9.30% |
| 2015-03-31 | $258.00K | 10.26% |
| 2014-12-31 | $234.00K | -0.85% |
| 2014-09-30 | $236.00K | -4.45% |
| 2014-06-30 | $247.00K | 18.75% |
| 2014-03-31 | $208.00K | 28.40% |
| 2013-12-31 | $162.00K | -14.29% |
| 2013-09-30 | $189.00K | -59.53% |
| 2013-06-30 | $467.00K | -61.85% |
| 2013-03-31 | $1.22M | 21.67% |
| 2012-12-31 | $1.01M | 15.50% |
| 2012-09-30 | $871.00K | 26.23% |
| 2012-06-30 | $690.00K | -62.80% |
| 2012-03-31 | $1.85M | 266.60% |
| 2011-12-31 | $506.00K | -51.39% |
| 2011-09-30 | $1.04M | 589.40% |
| 2011-06-30 | $151.00K | 0.67% |
| 2011-03-31 | $150.00K | 2.04% |
| 2010-12-31 | $147.00K | 15.75% |
| 2010-09-30 | $127.00K | 20.95% |
| 2010-06-30 | $105.00K | 2.94% |
| 2010-03-31 | $102.00K | -1.92% |
| 2009-12-31 | $104.00K | -27.78% |
| 2009-09-30 | $144.00K | 128.57% |
| 2009-06-30 | $63.00K | 53.66% |
| 2009-03-31 | $41.00K | -44.59% |
| 2008-12-31 | $74.00K | 57.45% |
| 2008-09-30 | $47.00K | -64.39% |
| 2008-06-30 | $132.00K | 247.37% |
| 2008-03-31 | $38.00K | -25.49% |
| 2007-12-31 | $51.00K | - |
Abeona Therapeutics generated $11.38M in revenue during Q2 2026, up 30.50% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Abeona Therapeutics Revenue Breakdown
Abeona Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 21 | Dec 20 | Dec 18 |
|---|---|---|---|---|
| License | $3.40M | $602.00K | - | - |
| Product | $2.42M | - | - | - |
| License and Other Revenues | - | $3.00M | $10.00M | - |
| Foundation | - | - | - | $5.71M |
Abeona Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: License (58.42%), and Product (41.58%).
Quarterly Revenue by Product
| Product/Service | Jun 26 | Mar 26 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|
| Product | $11.38M | $8.72M | - | - | - |
| Royalty | - | - | $113.00K | $22.00K | $17.00K |
| Grant | - | - | $369.00K | $1.69M | $802.00K |
Abeona Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Product (100.00%).
Abeona Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 | Dec 18 |
|---|---|---|---|
| License and Other Revenues | $3.00M | $10.00M | - |
| License | - | - | $602.00K |
| Foundation | - | - | $5.71M |
Abeona Therapeutics's latest annual revenue breakdown by geography, as of Dec 21: License and Other Revenues (100.00%).
Quarterly Revenue by Country
| Country | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|
| Grant | $369.00K | $1.69M | $802.00K |
| Royalty | $113.00K | $22.00K | $17.00K |
Abeona Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 18: Grant (76.56%), and Royalty (23.44%).
Abeona Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PBYI | Puma Bio | $228.37M | $56.50M |
| ARCT | Arcturus Therapeutics | $82.03M | $2.96M |
| VYGR | Voyager Therapeutics | $40.37M | $3.17M |
| FHTX | Foghorn Therapeutics | $30.91M | $16.07M |
| ABEO | Abeona Therapeutics | $5.82M | $11.38M |
| HUMA | Humacyte | $2.04M | $406.00K |
| TNYA | Tenaya Therapeutics | - | $1.11M |
| ASMB | Assembly Biosciences | - | - |
| SGMT | Sagimet Biosciences | - | - |
| ELDN | Eledon Pharmaceuticals | - | - |